News & Updates

Bedside genotype testing for mutations in the CYP2C19 gene helps select a better P2Y12 inhibitor treatment strategy for patients with ST-segment elevation myocardial infarction (STEMI) and leads to better outcomes relative to conventional therapy, a recent study has found.

The development of nonalcoholic fatty liver disease (NAFLD) and progression of fibrosis contribute to a higher risk of incident chronic kidney disease (CKD), suggests a recent study.

Treatment with corticosteroids (CS) among children with multisystem inflammatory syndrome (MIS-C) cardiovascular involvement temporarily associated with COVID-19 leads to faster normalization of left ventricular ejection fraction (LVEF), fever, improved laboratory analysis, and shorter intensive care unit stay than treatment with intravenous immunoglobulin (IVIG), a study has shown.

Both exogenous hyper- and hypothyroidism may increase the risk of incident stroke, according to a study, which notes the importance of patient medication safety.